Services

At Scopus Strategies, we recognise that each client engagement is unique. Our approach is tailored to meet the specific needs of your organisation and project. We offer expertise across five pillars:

  • Portfolio Strategy

  • Transaction Advisory

  • Competitive Intelligence

  • Clinical Strategy

  • Market Access

Our experience spans all therapeutic areas, with particular depth in oncology, rare diseases and immunology. We also bring specialised knowledge in cutting-edge fields like Artificial Intelligence and Cell & Gene Therapy.

Whether you’re navigating complex portfolio decisions, exploring market opportunities, or requiring swift, thorough due diligence for time-sensitive transactions, our team of experts craft bespoke solutions.

We leverage our broad therapeutic experience and deep industry insights to deliver strategies that drive your success across the entire drug development journey, adapting our processes to meet even the most demanding timelines.

Portfolio Strategy

Effective portfolio management is crucial in today’s rapidly changing pharmaceutical landscape. With increasingly complex products, evolving customer needs and intensifying competition, companies must optimise their portfolios to drive growth, improve profitability and deliver value to patients.

Our portfolio strategy services help you make better investment decisions.

  • Challenge we address

    Rapidly evolving competitive landscapes make it difficult to make informed decisions about assets, therapy areas and portfolios

    Solution

    Clear and impactful analysis of the evolving competitive landscape to support key asset, therapy area and portfolio decision making

  • Challenge we address

    Uncertainty in asset valuation and commercial potential due to complex market dynamics and multiple variables affecting outcomes

    Solution

    Detailed analysis of asset/TPP positioning, commercial potential and valuation, incorporating scenarios for key variables and value drivers

  • Challenge we address

    Difficulty in identifying and prioritising the most promising indication expansion opportunities that align with portfolio strategy

    Solution

    Systematic analysis to identify , profile, and prioritise indication expansion opportunities for integration into asset and portfolio strategy

  • Challenge we address

    Defining the optimal scope within a disease area whilst building a synergistic portfolio that does not cannibalise sales

    Solution

    Establish the boundaries of the indications in your selected disease area(s) whilst identifying the dynamics and value drivers that enable you to maximise the ROI of your disease area franchise

  • Challenge we address

    Creating a distinctive and compelling brand identity that resonates with diverse stakeholders in an increasingly crowded and competitive market

    Solution

    In-depth analysis to establish a clear patient-centric brand identity, define competitive positioning and develop a compelling brand narrative that resonates with all stakeholders

Transaction Advisory

Whether it’s partnering with other companies, acquiring new assets, or divesting underperforming products, strategic transaction can drive growth, improve profitability and shape the future of your business.

Our transaction advisory services help you navigate the complexities of these deals, providing guidance on structuring, due diligence, and integration strategies that meet your unique goals and needs.

  • Challenge we address

    Uncovering and accurately assessing all relevant risks and opportunities in prospective transactions

    Solution

    Comprehensive, multi-disciplinary due diligence covering scientific, regulatory, commercial, financial and operational aspects to provide a holistic view of transaction risks and opportunities

  • Challenge we address

    Accurately valuing assets or companies in an objective manner given the risk & uncertainty of drug development

    Solution

    Robust valuation methodologies including rNPV, real options analysis, comparable company analysis, deal benchmarking etc.

  • Challenge we address

    Identifying and executing optimal licensing deals that maximise value and align with strategic objectives in a competitive and fast-movinge environment

    Solution

    Strategic licensing support encompassing, opportunity identification, asset valuation, deal structuring, and negotiation guidance to optimise value creation in both out- and in-licensing scenarios

  • Challenge we address

    Comprehensively evaluating multiple strategic alternatives in a complex and uncertain pharmaceutical landscape

    Solution

    Systematic evaluation of strategic alternatives using modelling techniques, scenario planning and risk assessment to inform optimal transaction decisions

  • Challenge we address

    Seamlessly integrating two organisations while maintaining operational continuity, realising synergies and preserving key assets and talent

    Solution

    Structured post-merger integration approach focusing on cultural alignment, operational synergies and strategic portfolio optimisation, supported by change & program management

Competitive Intelligence

Staying ahead of the curve in pharma requires a deep understanding of market trends, competitor strategies and emerging opportunities. It is a critical foundation for informed decision-making allowing for the development of both proactive and reactive strategies to the competition.

Our competitive intelligence services arm you with actionable insights to inform critical business decisions.

  • Challenge we address

    Developing a deep, nuanced understanding of competitors' strategies, capabilities, and potential future moves in a complex industry

    Solution

    In-depth competitor profiling combining quantitative and qualitative insights to provide a comprehensive view of competitors' strengths, weaknesses, strategies and likely future actions

  • Challenge we address

    Preparing for uncertain future competitor actions in a rapidly evolving landscape

    Solution

    Dynamic scenario planning and interactive war gaming exercises that explore multiple potential events, stress-test strategies, and develop proactive and reactive strategies to market events

  • Challenge we address

    Presenting complex competitive intelligence data in a clear, accessible format that facilitates decision-making at all levels

    Solution

    Tailored, interactive dashboards and analytics platforms that transform complex competitive data into clear, actionable visualisations, enabling rapid insights and informed decision making

  • Challenge we address

    Staying abreast of competitors' activities and market changes in real-time across a vast and complex pharmaceutical landscape

    Solution

    Comprehensive, real-time competition monitoring leveraging advanced data aggregation and analysis techniques to provide timely, actionable insights on competitor activities and market shifts

  • Challenge we address

    Identifying and interpreting critical scientific and clinical developments that could impact the competitive landscape, often before they become widely known

    Solution

    Systematic monitoring and analysis of scientifc conferences and literature, providing early insights into emerging technologies, potential new therapies, and evolving treatment paradigms

Clinical Strategy

Optimising your clinical development plan is crucial for differentiation and bringing a synergistic franchise to patients. With increasing complexity in trial designs, evolving regulatory requirements, and intensifying competition, companies must develop effective clinical trial strategies to drive success.

Our clinical strategy services help you navigate the complexities of clinical trial planning and strategic development to meet your unique goals and needs.

  • Challenge we address

    Accurately assessing the viability and potential challenges of clinical trials in diverse global settings with varying patient populations and healthcare infrastructures

    Solution

    Comprehensive assessments analysing data on trial timing, enrolment metrics, study timelines, patient populations and geographic variation to optimise site selection, and patient recruitment strategies

  • Challenge we address

    Effectively comparing and optimising clinical trial performance against industry standards and best practices

    Solution

    Performance analysis of clinical trials, providing actionable insights on timelines, costs, recruitment rates, and operational efficiency to enable strategic optimisation of trial design

  • Challenge we address

    Developing clinical trial protocols that balance scientific rigor, regulatory compliance, patient-centricity and operational efficiency

    Solution

    Data-driven protocol design optimisation that integrates analysis of successful trial designs with current regulatory insights, tailoring protocols to specific candidates and patient populations

  • Challenge we address

    Gathering comprehensive and timely intelligence on competitors' trials, including protocols, enrolment status and results

    Solution

    Timely clinical trial analyses or updating dashboard allowing clients to anticipate competitive threats to their programs by understanding competitor clinical strategies and their likely timelines

Market Access

The healthcare landscape across markets is constantly in flux, and getting health technologies to patients has become a complex undertaking. Market access is critical for biopharma companies seeking to bring their innovations to the people who need them.

Our market access services help you navigate this ever-changing landscape.

  • Challenge we address

    Developing a comprehensive market entry plan that addresses diverse stakeholder needs, complex reimbursement landscapes and varying healthcare systems

    Solution

    Holistic go-to-market strategy development incorporating in-depth market analysis, stakeholder mapping, and value proposition refinement to optimise product launch and penetration

  • Challenge we address

    Navigating the complex and rapidly evolving market access landscape, including payer dynamics, policy changes and emerging access models

    Solution

    Landscape assessments leveraging multiple data sources and analytics to provide actionable insights on market access trends, payer behaviours & access models

  • Challenge we address

    Identifying and prioritising KOLs who can significantly influence product adoption and patient access

    Solution

    KOL mapping and influence analysis, utilising social network analytics and publication impact assessments to identify and prioritise key influencers across stakeholder groups

  • Challenge we address

    Understanding the complex patient journey from diagnosis to treatment to identify key intervention points and optimise access strategies

    Solution

    Detailed patient journey mapping combining real-world data analysis, qualitative research and heathcare system insights to identify critical touchpoints and optimise engagement

  • Challenge we address

    Developing optimal pricing and reimbursement strategy development, integrating market analytics, payer research and value demonstration

    Solution

    Data-driven pricing and reimbursement strategy development, integrating market analytics, payer research, and value demonstration frameworks to optimise product value capture